PharmEasy, one of India’s leading healthcare platforms, today released the PharmEasy Health Report 2025, an annual, data-led ...

Earlier this week, Viatris announced four pipeline milestones, including US FDA approval of its generic version of Sandostatin LAR Depot and regulatory progress on a low-dose contraceptive patch, an ...

ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ -- Abu Dhabi Finance Week (ADFW), the flagship event hosted by ADGM, continued for a second day with Asset Abu Dhabi, bringing together some of the world's ...

Stock market graphs don’t have to be a mystery. Here’s how to read stock charts for any company. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

Perimenopausal women face increased pregnancy-related risks, necessitating continued contraceptive use until menopause is confirmed. Healthy women can use combination hormonal contraceptives until mid ...

Chartis Research and Metrika today announced the release of a collaborative report titled "Managing Digital Asset Risk Using an Integrated, Composable Framework," establishing a new approach to ...

The first female oral contraceptive was approved by the US Food and Drug Administration in 1960. In the 65 years since its inception, it has become a commonly used drug. The same cannot be said for ...

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in ...

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies. Referred to as “Royalty Management Co” and ...

Women lined up for hours, some after days of travel. I met them almost 20 years ago at contraceptive clinics in Uganda and Kenya. They told me, “This will free me to work and feed the children I have.